1/48
Vocabulary flashcards covering key terms from the DNA repair and recombination lecture notes.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Mutagens
Agents that damage DNA.
Radiation
Mutagenic energy sources such as x-rays and UV light.
Benzo[a]pyrene
Chemical mutagen found in cigarette smoke.
Aflatoxins
Natural products (in mushrooms) that are mutagenic.
Carcinogens (as described in notes)
Carcinogens do not directly damage DNA (examples: H. pylori, alcohol, asbestos in notes).
Endogenous mutagens
Mutagens generated by metabolic reactions inside the cell.
Reactive oxygen species (ROS)
Chemically reactive oxygen-containing molecules that cause base oxidation and DNA strand interruptions.
Mismatched base pairs
Incorrect base pairs resulting from errors during replication.
Deamination
Hydrolysis removing an amino group from a base, altering base identity.
Depurination
Loss of a purine base (A or G) from DNA.
Depyrimidination
Loss of a pyrimidine base (C or T) from DNA.
Alkylation of bases
Addition of alkyl groups (often methylation) to bases.
Exogenous mutagens
Mutagens introduced from outside the cell (environmental agents).
UV light
Exogenous mutagen that crosslinks bases and forms pyrimidine dimers.
Pyrimidine dimers
C-C or T-T crosslinks caused by UV light, distorting DNA.
Ionizing radiation
Radiation that causes DNA strand breaks.
DNA adducts
Covalent attachments of mutagenic chemicals to DNA bases.
Intercalating agents
Molecules that insert between base pairs, disrupting replication.
Ethidium bromide
Intercalating agent used as a DNA stain; example of intercalator.
Doxorubicin
Chemotherapeutic intercalating agent used in cancer treatment.
Thalidomide
Intercalating agent listed among mutagen/intercalator examples; used in therapy.
Substitution mutations
One base replaced by another in DNA.
Deletion mutations
Loss of one or more bases from DNA.
Insertion mutations
Addition of one or more bases into DNA.
Transition
Substitution of a purine for a purine (A↔G) or a pyrimidine for a pyrimidine (C↔T).
Transversion
Substitution of a purine for a pyrimidine or vice versa.
Base Excision Repair (BER)
Repair pathway that removes damaged bases via DNA glycosylases, AP endonuclease, and fills/gaps with polymerase and ligase.
DNA glycosylases
Enzymes that remove damaged bases in BER by cleaving the glycosidic bond.
AP endonuclease
Enzyme that cleaves the abasic site created after base removal.
DNA polymerase
Enzyme that fills in the DNA gap during repair.
DNA ligase
Enzyme that seals nicks in the DNA backbone after repair.
Long patch repair
BER pathway variant that uses longer replacement DNA synthesis (displacing).
Short patch repair
BER variant with minimal replacement of a few nucleotides.
Nucleotide Excision Repair (NER)
Repair pathway correcting bulky lesions like pyrimidine dimers; major defense against UV and cigarette smoke damage.
Pyrimidine dimers
Crosslinked cytosine and thymine bases caused by UV exposure.
DNA repair steps (NER)
Nuclease cuts damaged strand at two points; repair synthesis fills gap; ligase seals.
Xeroderma pigmentosum (XP)
Disease caused by failed NER leading to extreme UV sensitivity and cancer risk.
Mismatch Repair (MMR)
Repair pathway recognizing mismatches; bacteria use hemi-methylation to distinguish strands; defects cause diseases like FAP.
Direct Repair
Repair pathway that directly reverses damage, e.g., photoreactivation of pyrimidine dimers by photolyase.
DNA photolyase
Enzyme with cofactors (N5,N10-methenyltetrahydrofolate and FAD) that reverses pyrimidine dimers using light.
Transposons
“Jumping genes” that move within the genome via transposase.
Transposase
Enzyme that cleaves/moves transposons within DNA.
Translocations
Chromosomal breaks that join ends of different chromosomes, causing rearrangements.
Philadelphia chromosome
t(9;22) translocation creating Bcr-Abl fusion gene; tyrosine kinase driving CML.
Bcr-Abl
Fusion tyrosine kinase from Philadelphia chromosome; constitutively active and promotes proliferation.
Imatinib
Small-molecule inhibitor used to treat CML by inhibiting Bcr-Abl kinase.
Crossing-over
Meiotic recombination event exchanging DNA between homologous chromosomes.
Meiosis
Cell division producing gametes with half the chromosome number; site of crossing-over.
Lymphocyte differentiation
Process during which crossing-over occurs for antibody diversity.